If you experience any suspected side effects from Rybelsus, even after stopping the medication, report them via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
Do not eat or drink for 30 minutes after dosing
7.2 mg weekly (Wegovy HD) for adults who tolerated 2.4 mg for at least 4 weeks and need more weight loss
In rare cases, GLP-1 medication can also cause low blood sugar levels
Rotate injection sites to prevent localized tissue issues
Seek immediate medical attention (call 999 or attend A&E) if you develop: Severe, persistent abdominal pain (potential pancreatitisa rare but serious side effect) Signs of severe dehydration with altered consciousness Symptoms of diabetic ketoacidosis (though rare in type 2 diabetes and more likely if insulin is reduced abruptly or when taking SGLT2 inhibitors) Your healthcare team can assess whether fatigue relates to Ozempic, underlying diabetes control, other medications, or separate medical conditions such as anaemia, thyroid dysfunction, or vitamin deficiencies all of which are more common in people with diabetes
:max_bytes(150000):strip_icc()/VWH-AmeliaManley-OzempicvsWegovyvsMounjaro-dc80b8c8de6243ec9b984cd4b5db5db4.jpg)
